Corticosteroid and Immunosuppressive Management in AIHA Patients with Severe Infection

Continuation of Corticosteroids

• In patients with autoimmune hemolytic anemia (AIHA) who are already receiving corticosteroids, therapy should be continued during a severe infection because abrupt withdrawal can precipitate adrenal insufficiency and trigger an AIHA flare. 1

Handling of Steroid‑Sparing Immunosuppressants

• The decision to hold or discontinue steroid‑sparing agents such as azathioprine or mycophenolate mofetil should be guided by the severity of the concurrent infection; in grade 3‑4 infections these agents should be permanently stopped while maintaining corticosteroids. 2, 3
• For moderate hemolysis (hemoglobin 8–10 g/dL) the steroid‑sparing agents are held, but prednisone is continued at 0.5–1 mg/kg/day. 1

Infection Surveillance and Prevention

• Strict infection surveillance is mandatory for any AIHA patient receiving corticosteroids, especially during acute severe presentations, to detect bacterial or viral triggers (e.g., Mycoplasma, CMV, parvovirus). 4

Diagnostic Workup During Infection

• Baseline laboratory evaluation should include a complete blood count with peripheral smear to confirm ongoing hemolysis. 2
• Additional labs—lactate dehydrogenase, haptoglobin, indirect/direct bilirubin, and reticulocyte count—are required to quantify hemolysis severity. 2
• A coagulation panel (PT/INR) should be obtained to screen for disseminated intravascular coagulation. 2
• Blood cultures and a full infectious‑disease work‑up are essential to identify the underlying pathogen. 2
• Review current medications and exclude drug‑induced hemolysis from antibiotics, NSAIDs, or antivirals. 2

Treatment Algorithms by Hemolysis Grade

Grade 1 (Mild Hemolysis, Hb > 10 g/dL)

• Continue the existing immunosuppressive regimen with close monitoring; treat the infection aggressively with appropriate antimicrobials and obtain at least three CBC measurements during the infection course. [2] [1]

Grade 2 (Moderate Hemolysis, Hb 8–10 g/dL)

• Hold steroid‑sparing agents, maintain prednisone 0.5–1 mg/kg/day, consider hospital admission for close observation, and transfuse red blood cells only to the minimum target (Hb 7–8 g/dL). [1] [3]

Grade 3‑4 (Severe or Life‑Threatening Hemolysis, Hb < 8 g/dL)

• Admit the patient immediately, permanently discontinue all steroid‑sparing immunosuppressants, and start high‑dose prednisone 1–2 mg/kg/day (intravenous methylprednisolone if oral intake is not possible).
• Obtain an urgent hematology consult, and if hemolysis worsens despite steroids, add IVIG (2 g/kg over 2–5 days), rituximab, or plasma exchange. [2] [5]
• Coordinate with the blood bank before any transfusion to ensure compatibility and minimize hemolytic risk. 3

Infection‑Related Triggers of AIHA

• Hepatitis A, hepatitis E, cytomegalovirus, Epstein–Barr virus, and Mycoplasma infections can precipitate or mimic AIHA, necessitating targeted antimicrobial therapy. 6

Contraindicated Therapies in the Setting of Infection

• Intravenous anti‑D should be avoided in AIHA patients with concurrent infection because it may exacerbate hemolysis. 7

Post‑Infection Immunosuppression Strategy

• After infection resolution, reassess the need for steroid‑sparing agents; if they have been held for more than three months, document a risk‑benefit discussion before restarting.
• Resume immunosuppressive therapy gradually, with close monitoring for any recurrence of infection. 1